1. Orphan Drugs for Rare Diseases

   • Steven Simoens
   • David Cassiman
   • Eline Picavet

   Current Opinion 06 January 2012 Pages: 1437 - 1443

2. Therapeutic Potential of Mipomersen in the Management of Familial Hypercholesterolaemia

   • Carmen Gelsinger
   • Elisabeth Steinhagen-Thiessen
   • Ursula Kassner

   Leading Article 06 January 2012 Pages: 1445 - 1455

   

3. Delirium in Critically Ill Patients

   • Irene J. Zaal
   • Arjen J. C. Slooter

   Therapy In Practice 06 January 2012 Pages: 1457 - 1471

   

4. Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections

   • Thomas P. Lodise
   • Donald E. Low

   Review Article 06 January 2012 Pages: 1473 - 1493

   

5. Ten Years of Experience with Biphasic Insulin Aspart 30

   • Andreas Liebl
   • Vinay Prusty
   • Viswanathan Mohan

   Review Article Open access 06 January 2012 Pages: 1495 - 1520

   

6. Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis

   • Lin-lin Liu
   • Yi Jiang
   • Zi-long Li

   Systematic Review 06 January 2012 Pages: 1521 - 1533

   

7. Vismodegib

   • Gillian M. Keating

   Adis Drug Profile 06 January 2012 Pages: 1535 - 1541

   

8. A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel®]

   • Greg L. Plosker

   Adis Drug Profile 06 January 2012 Pages: 1543 - 1557

   

9. Docetaxel

   • Kate McKeage

   Adis Drug Evaluation 06 January 2012 Pages: 1559 - 1577

   

10. Erratum to Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemia

    • G. M. Keating

    Erratum 06 January 2013 Pages: 1578 - 1578